Stay informed with the latest pharma industry news and insights by signing up for PharmaVoice. Explore all our free newsletter options here: https://lnkd.in/gP2m_c7J
PharmaVoice
制药业
Washington，District of Columbia 12,294 位关注者
Covering everything from Molecule to Market
关于我们
PharmaVoice is for life-sciences executives and other healthcare-service related professionals. The primary audience is made up of executive and corporate management from pharmaceutical, biotechnology, drug delivery, marketing communications, clinical services, contract research, drug development, and information technology companies, as well as other industry sectors. Additionally, PharmaVoice.com has readers from around the world. Subscribe to the daily newsletter at https://dive.pub/3ruPmUL
- 网站
-
https://www.pharmavoice.com
PharmaVoice的外部链接
- 所属行业
- 制药业
- 规模
- 11-50 人
- 总部
- Washington，District of Columbia
- 类型
- 私人持股
- 领域
- pharmaceutical、biotechnology、medical devices、life sciences、advertising、marketing、publishing、digital media、editorial、content generation、digital marketing和marketing strategy
地点
-
主要
获取路线
1100 15th St NW
4th Floor - (Suite 178)
US，District of Columbia，Washington，20005
PharmaVoice员工
动态
-
Despite a plan to shutter 1,200 stores, Walgreens remains committed to drug research. “We are in lock step with the wider business model,” says Ramita Tandon, Walgreens' chief clinical trials officer. https://lnkd.in/eZAiP-y3
Will Walgreens’ store closures derail its clinical trial aims?
pharmavoice.com
-
It’s still likely U.S. biotechs and pharmas will have to cut ties with key Chinese partners due to the Biosecure Act — it’s just a matter of when. “The [U.S.] industry is already starting to actively move away from Chinese biotechs,” says Matt Wetzel, life sciences regulatory and compliance partner at Goodwin. “The bell has been rung and cannot be unrung.” #pharma #biotech https://lnkd.in/e8VurJfH
What might a Trump administration mean for the Biosecure Act?
pharmavoice.com
-
Leaders in the pharma industry are finally getting comfortable with a word they used to shy away from: cure. “‘Cure’ is one of the most misunderstood terms in medicine,” says Jochen Salfeld, AbbVie’s vice president of virology discovery research and head of R&D cures. #pharma #genetherapy https://lnkd.in/eabifeDX
What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
pharmavoice.com
-
Merck’s acquisition of Modifi Bio bucks common M&A trends in pharma. The drugmaker is dropping upwards of $1.3 billion on the deal anyway. “What Merck recognizes is that it’s a whole new way to treat tumors. ... We call it precision chemotherapy," says Dr. Ranjit Bindra, co-founder of Modifi. #cancer #glioblastoma #biotech https://lnkd.in/eFvJZmi5
Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug
pharmavoice.com
-
As quickly as they rose to prominence during the pandemic, many biotechs fell just as rapidly back down to earth. Here’s where four biotechs have landed since their initial ascent to COVID fame. CureVac Novavax INOVIO Pharmaceuticals, Inc. Veru Inc. #biotech #vaccines #covid https://lnkd.in/eTa35_qj
Where are they now? 4 biotechs that soared then crashed during the pandemic
pharmavoice.com
-
When "pharma bro" Martin Shkreli left Turing Pharmaceuticals in handcuffs, Ron Tilles had to pick up the pieces and stepped into the interim CEO role. Here's his story. #pharma https://lnkd.in/eY8CSAdj
Left to clean up after ‘pharma bro’ Shkreli’s arrest, former Turing CEO Ron Tilles reckons with the past
pharmavoice.com
-
Another side of a story you might be familiar with: When "pharma bro" Martin Shkreli left Turing Pharmaceuticals in handcuffs, here's the interim CEO who had to pick up the pieces. Lessons learned? Read more at PharmaVoice.
Left to clean up after ‘pharma bro’ Shkreli’s arrest, former Turing CEO Ron Tilles reckons with the past
pharmavoice.com
-
Quirky ads that aim to raise awareness about diseases or drugs can make an important impression on patients and consumers. Drugmakers with first-in-class or first-in-disease treatments are also taking novel approaches to promote their products. Check out three unique marketing plays in 2024 from the pharma world. Astellas Pharma Genentech Reckitt #pharma #commercialization https://lnkd.in/eGwpHna8
From Mr. Mucus to the Super Bowl, pharma tries offbeat marketing strategies
pharmavoice.com
-
Will direct-to-patient telehealth prescription platforms from drugmakers like Pfizer and Eli Lilly and Company be a tool to make healthcare more convenient for patients or an illegal strategy to increase drug sales? A group of U.S. senators has sent letters to both companies looking for an answer. #pharma #DTC https://lnkd.in/ehzfSa9Q
Pfizer and Lilly’s telehealth prescribing platforms draw Senate scrutiny for ‘potential fraud’
pharmavoice.com